Skip to main content
SpringerLink
Log in

The Use of Complementary and Alternative Therapies in Older Women

  • Chapter
Alternative Medicine for the Elderly

  • 285 Accesses

Abstract

Menopause is a natural, inevitable process in most women. Physiologically, there is decreasing development of ovarian follicles, which causes a significant drop in production of estradiol and other hormones. Ultimately, there is cessation of menses. During the years surrounding the final menses, a majority of women experience some symptoms related to the declining hormone levels such as hot flashes, vaginal dryness, irregular menses, and mood swings or irritability. In the years following menopause other health problems arise due to the long-term consequences of decreased hormone production. Bone loss occurs at a rapid rate perimenopausally, then continues at a slower rate throughout the rest of a woman’s life. With the average age of menopause being 50 years, most women will have over thirty years to lose bone. Estrogen replacement therapy has been used successfully to prevent and treat osteoporosis [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weiss NS (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. NEJM; 303: 1195–1198

    Article  PubMed  CAS  Google Scholar 

  2. Genant HK (1997) Low-dose esterified estrogen therapy: Effects on bone, plasma estradiol, endometrium and lipid levels. Arch Intern Med; 157: 2609–2615.)

    Google Scholar 

  3. The PEPI investigators (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273: 199–208.

    Article  Google Scholar 

  4. Mendelsohn ME (1999) The protective effects of estrogen on the cardiovascular system. NEJM; 340: 1801–1811.

    Article  PubMed  CAS  Google Scholar 

  5. Utian WH (1999) Efficacy and safety of low, standard and high dosages of an estradiol transdermal system compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. Am J Obstet Gynecol; 181: 71–79

    Article  PubMed  CAS  Google Scholar 

  6. Grodstein F (1999) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med;128: 705–712), cognitive decline and dementia

    Google Scholar 

  7. LeBlanc ES (2001) Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA; 285: 1489–1499.

    Article  PubMed  CAS  Google Scholar 

  8. Wluka AE (2000) Menopause, oestrogens and arthritis. Maturitas; 35: 183–199.

    Article  PubMed  CAS  Google Scholar 

  9. Fantl JA (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: A Meta-analysis: First report of the hormones and urogenial therapy committee. Obstet Gynecol; 83: 12–18

    PubMed  CAS  Google Scholar 

  10. Cauley JA (1990) Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol; 163: 1438–1444.

    PubMed  CAS  Google Scholar 

  11. Menopause 2001; 8 (6): 433–440

    Google Scholar 

  12. Alternative Medicine; Expanding Medical Horizons. A report to the NIH on Alternative Medical Systems and Practices in the United States. US Gov’t Printing Office 017–040–00537–7

    Google Scholar 

  13. Eisenberg D, Kessler RC, Foster C, Norlock FE, Calkins DR, DelBanco TL. (1993) Unconventional medicine in the United States-prevalence cost and patterns of use. NEJM; 328: 246–252.

    Article  PubMed  CAS  Google Scholar 

  14. Eisenberg DM et al (1990) Trends in Alternative Medicine use in the U.S. 1990–1997. JAMA; 280: 1569–75.

    Article  Google Scholar 

  15. Landmark Healthcare, Sacramento, CA; The Integrator for the Business of Alternative Medicine. 1999; vol3.

    Google Scholar 

  16. Palinkas LA et al. (2000) The use of CAM by primary care patients. J Fam Pract; 49: 1121–1130.

    PubMed  CAS  Google Scholar 

  17. Mathuna DP (2000) Where to with herbals. Alternative Therapies. 6: 34–35.

    Google Scholar 

  18. Foster S, (1999) Black Cohosh: A literature review. Herbalgram; 45: 35–49.

    Google Scholar 

  19. Duker EM (1991) Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med.; 57: 420–424

    Article  PubMed  CAS  Google Scholar 

  20. Liske E (1998) Therapy of Climacteric Complains with Cimicifuga racemosa. Menopause; 5: 250.

    Article  Google Scholar 

  21. Liske P (1998) Therapeutic efficacy and safety of Cimicifuga racemosa for gynecological disorders. Advances in Therapy; 15: 45–53.

    PubMed  CAS  Google Scholar 

  22. Stoll W (1987) Phytopharmacon influences atrophic vaginal epithelium: double-blind study–cimicifuga vs. estrogenic substances. Therapeuticum; 1: 23–31.

    Google Scholar 

  23. Ozaki Y, (1990) Inhibitory effects of tetramethylpyrazine and ferulic acid on spontaneous movement of rat uterus in situ. Chem Pha; 38: 1620–1623.

    Article  CAS  Google Scholar 

  24. Rotblatt MD (1999) Dong Quai: A review.; 1: 65–72.

    Google Scholar 

  25. Hirata JD et al. (1997) Does Don quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril; 68: 981–6

    Article  PubMed  CAS  Google Scholar 

  26. Blatt MHG, Wiesbader H, Kupperman HS (1953) Vitamin E and climacteric syndrome: failure of effective control as measured by menopausal index. Arch Intern Med; 91: 792–9.

    CAS  Google Scholar 

  27. Natural Medicines Comprehensive Database compiled by the editors of Prescriber’s Letter and Pharmacists Letter. Published by Therapeutic Research Faculty, Stockton, California. 2000 p. 422

    Google Scholar 

  28. Chenoy R Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994; 308: 501–503.)

    Google Scholar 

  29. Natural Medicines Comprehensive Database compiled by the editors of Prescriber’s Letter and Pharmacists Letter. Published by Therapeutic Research Faculty, Stockton, California. 2000 p. 1053.

    Google Scholar 

  30. Hardy ML. (1999) Valerian Root for Insomnia. Alt Med Alert.; 2: 85–96.

    Google Scholar 

  31. Donath F et al. (2000) Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33: 47–53.

    Article  PubMed  CAS  Google Scholar 

  32. Garges HP et al. (1998) Cardiac complications and delirium associated with Valerian Root withdrawal. JAMA; 280: 1566–1567.

    Article  PubMed  CAS  Google Scholar 

  33. Pittler MH and Ernst E. (2000) Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol; 20: 84–9.

    Article  PubMed  CAS  Google Scholar 

  34. Natural Medicines Comprehensive Database compiled by the editors of Prescriber’s Letter and Pharmacists Letter. Published by Therapeutic Research Faculty, Stockton, California. 2000 p. 626.

    Google Scholar 

  35. Almeida JC et al. (1996) Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med; 125: 940–941.

    PubMed  CAS  Google Scholar 

  36. Herbal Rx Promises and Pitfalls. Consumer Reports. March 1999, pp 44–48.

    Google Scholar 

  37. Herbal Roulette. Consumer Reports. November 1995: 698–705.

    Google Scholar 

  38. Natural Medicines Comprehensive Database compiled by the editors of Prescriber’s Letter and Pharmacists Letter. Published by Therapeutic Research Faculty, Stockton, California. 2000. p. 733.

    Google Scholar 

  39. Vogler BK (1999) The efficacy of ginseng. A systematic review of randomized clinical trials. Eur J Clin Pharmacol. 55: 567–575

    Article  PubMed  CAS  Google Scholar 

  40. Vuksan V et al. (2000) American ginseng reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes. Arch Intern Med; 160: 1009–1013.

    Article  PubMed  CAS  Google Scholar 

  41. Hopkins MP, et al. (1983) „Ginseng ace cream and unexplained vaginal bleeding. Am J Obstest Gynecol 1988; 159: 1121–2, Greenspan EM „Ginseng and vaginal bleeding“ JAMA; 249: 2018.

    Google Scholar 

  42. Miller LG (1998) Herbal Medicinals. Arch Intern Med; 158: 2200–2211.

    Article  PubMed  CAS  Google Scholar 

  43. Tyler VE, Herbs of Choice. Pharmaceutical Products Press, NY 1994, p. 80.

    Google Scholar 

  44. Howell AB (1998) Inhibition of the adherence of P-fimbriated E. coli to uroepithelial cell surfaces by proanthocamidin extracts from cranberries NEJM; 339: 1085–1086

    CAS  Google Scholar 

  45. Avorn J (1994) Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA; 271: 751–4

    Article  PubMed  CAS  Google Scholar 

  46. Kontiokari T (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ; 322: 1571–3.

    Article  PubMed  CAS  Google Scholar 

  47. Terris MK (2001) Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology: 57: 26–29.

    Article  PubMed  CAS  Google Scholar 

  48. Vincent A, Fitzpatrick LA. (2000) Soy Isoflavones: Are they Useful in Menopause? Mayo Clin Proc; 75: 1174–1184.

    Article  PubMed  CAS  Google Scholar 

  49. Murkies AL (1998) Phytoestrogens J Clin Endocrinol Metab; 83: 297–303.

    Article  CAS  Google Scholar 

  50. Tham DM. (1998) Potential Health Benefits of Dietary Phytoestrogens: A Review of the Clinical, Epidemiological and Mechanistic Evidence. J Clin Endocrinol Metab; 83: 2223–2235.

    Article  PubMed  CAS  Google Scholar 

  51. NAMS Consensus Opinion (2000) The Role of Isoflavones in Menopausal Health: Consensus Opinion of The North American Menopause Society. Menopause; 7: 215–229.

    Article  Google Scholar 

  52. Nisly N (1999) Phytoestrogens for the prevention and treatment of osteoporosis. Alt Med Alert; 2 (12): 138–142.

    Google Scholar 

  53. Schreiber MD (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause; 8: 384–392.

    Article  Google Scholar 

  54. Kim H (1998) Mechanisms of action of the soy isoflavone genistein. Am J Clin Nutr; 68: 14185–1425S.

    Google Scholar 

  55. Hutchins (1995) Vegetables, fruits and legumes: effect on urinary isofavonoid phytoestrogen and lignan excertion. J Am Diet Assoc; 95: 769–774.

    Article  PubMed  CAS  Google Scholar 

  56. Aldercreutz H (1997) Phytoestrogens and Western diseases. Ann Med; 29: 95–120.

    Google Scholar 

  57. Gold EB (2000) Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women. Am J Epidemiol; 152: 463–83.

    Article  PubMed  CAS  Google Scholar 

  58. Washburn S (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure and menopausal symptoms in perimenopausal women. Menopause; 6 (1): 7–13.

    Article  PubMed  CAS  Google Scholar 

  59. Albertazzi P (1998) The effect of dietary soy supplementation on hot flashes. Obstet Gynecol; 91: 9–11.

    Article  Google Scholar 

  60. Murkies AL (1995) Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas; 21: 189–195.

    Article  PubMed  CAS  Google Scholar 

  61. St. Germain A (2001) Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 8: 17–26.

    Google Scholar 

  62. Quella SK (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors. J Clin Onc; 18 (5): 1068–74.

    CAS  Google Scholar 

  63. Brzezinski A (1997) Short-term effects of phytoestrogen rich diet on postmenopausal women. Menopause; 4 (2): 89–94.

    Article  Google Scholar 

  64. Scambia G (2000) Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause; 7 (2): 105–111.

    Article  PubMed  CAS  Google Scholar 

  65. Upmalis DH (2000) Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause; 7 (4): 236–242.

    Article  PubMed  CAS  Google Scholar 

  66. Baber RJ (1999) Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 2: 85–92.

    Article  PubMed  CAS  Google Scholar 

  67. Knight DC (1999) The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric; 2: 79–84.

    Article  PubMed  CAS  Google Scholar 

  68. FDA talk paper: FDA approves new health claim for soy protein and coronary heart disease.

    Google Scholar 

  69. Anderson JW (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med; 333: 276–82.

    Article  PubMed  CAS  Google Scholar 

  70. Crouse JR (1999) A randomized trial comparing the effect of casein with soy protein on plasma concentrations of lipids and lipoproteins. Arch Intern Med; 159: 2070–76.

    Article  PubMed  CAS  Google Scholar 

  71. Potter SM (1998) Soy protein and isoflavones: their effects on lipids and bone density in postmenopausal women. Am J Clin Nutr; 68: 1375S - 1379S.

    PubMed  CAS  Google Scholar 

  72. Lu LJW (2001) Phytoestrogens and healthy aging: gaps in knowledge. Menopause; 8: 157–170.

    Article  PubMed  CAS  Google Scholar 

  73. Clifton-Bligh PB (2001) The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause; 8: 259–265.

    Article  PubMed  CAS  Google Scholar 

  74. Nestle PI (1999) Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab; 84: 895–8.

    Article  Google Scholar 

  75. Alekel DL (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr; 72: 844–52.

    PubMed  CAS  Google Scholar 

  76. Goodman MT (1997) Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146: 294–306.

    Article  PubMed  CAS  Google Scholar 

  77. Murkies A (2000) Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 7 (5): 289–96.

    Article  PubMed  CAS  Google Scholar 

  78. Ingram D (1997) Case-control study of phyto-estrogens and breast cancer. Lancet. 350: 990–994.

    Article  PubMed  CAS  Google Scholar 

  79. Wu AH (1998) Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr. 68 (6suppl): 1437S - 43S.

    PubMed  CAS  Google Scholar 

  80. Balk JL (2000) Ipriflavone for prevention of osteoporosis. Alternative Medicine Alert 3 (12): 133–144.

    Google Scholar 

  81. Nisly N (2000) Ipriflavone: Mechanism and safety. Alternative Therapies in Women’s Health. 2 (9): 65–72.

    Google Scholar 

  82. Yamazaki I (1986) Effects of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci 38: 951–8.

    Article  PubMed  CAS  Google Scholar 

  83. Gennari C (1998) Effect of ipriflavone on bone mass loss in the early years after menopause. Menopause 5: 9–15.

    Article  PubMed  CAS  Google Scholar 

  84. Valente M (1994) Effects of one year treatment with ipriflavone in postmenopausal women with low bone mass. Calcif Tissue Int 54: 377–380.

    Article  PubMed  CAS  Google Scholar 

  85. Melis GB (1992) Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium. Bone Miner 19 (suppl 1): S49–56.

    Article  PubMed  CAS  Google Scholar 

  86. Agnuside D (1995) Prevention of early postmenopausal bone loss using low dose conjugated estrogen and ipriflavone. Osteoporosis Int 5: 462–6.

    Article  Google Scholar 

  87. Gennari C (1997) Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcif Tissue Int 61 (51): 19–22

    Article  Google Scholar 

  88. Gambacciani M (1997) Effects of combined low dose ipriflavone and ERT on bone mineral density and metabolism in postmenopausal women. Maturitas; 28: 75–81.

    Article  PubMed  CAS  Google Scholar 

  89. Ushiroyama T (1995) Efficacy of ipriflavone and vertebral vitamin D for the cessation of bone loss Int J Gynecol Obstet; 48: 283–288.

    CAS  Google Scholar 

  90. Maugeri D (1994) Ipriflavone treatment of senile osteoporosis: Results of a multi-center double-blind randomized trial of 2 years. Arch Gerentol Geriatr; 19: 253–63.

    Article  CAS  Google Scholar 

  91. Alexandersen P (2001) Ipriflavone in the treatment of postmenopausal osteoporosis. JAMA 285: 1482–1488.

    Article  PubMed  CAS  Google Scholar 

  92. Lee JR (1998) Use of Pro-Gest cream in postmenopausal women. Lancet. 352: 905–6

    Article  PubMed  CAS  Google Scholar 

  93. Carey BJ (2000) A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women. BJOG 107: 722–6.

    Article  PubMed  CAS  Google Scholar 

  94. Anasti JN (2001) Topical progesterone cream has antiproliferative effect on estrogen-stimulated endometrium. Obstet Gynecol 97 (4 Suppl 1): StO

    Google Scholar 

  95. Wren BG (1999) Micronised transdermal progesterone and endometrial response. Lancet 354: 1447–8.

    Article  PubMed  CAS  Google Scholar 

  96. Leonetti HB (1999) Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 94 (2): 225–8.

    Article  PubMed  CAS  Google Scholar 

  97. Fugh-Berman A (1999) Progesterone cream for osteoporosis. Alt therapies in women’s health 1: 33–36.

    Google Scholar 

  98. Langer RD (1999) Micronized progesterone: A New Therapeutic Option. Int J Fertil 44: 67–73.

    CAS  Google Scholar 

  99. Weiderpass E (1999) Low-potency oestrogen and risk of endometrial cancer: A case-control study. Lancet, 353: 1824–1828.

    Article  PubMed  CAS  Google Scholar 

  100. Ginty F, Flynn A et al. (1998) The effect of dietary sodium intake on biochemical markers of bone metabolism in young women. Br J Nutr; 79 (4): 343–50.

    Article  PubMed  CAS  Google Scholar 

  101. Evans CE, Chughtai AY et al. (1997) The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women. Eur J Clin Nutr; 51 (6): 394–9.

    Article  PubMed  CAS  Google Scholar 

  102. Barzel US, Massey LK. (1998) Excess dietary protein can adversely affect bone. J of Nutr; 128 (6): 1051–3.

    CAS  Google Scholar 

  103. Kerstetter JE, Mitnick MA et al. (1999) Changes in bone turnover in young women consuming different levels of dietary protein. J Clin Epidem and Met; 84 (3): 1052–5.

    Article  CAS  Google Scholar 

  104. Feskanich D, Willet WC et al. (1996) Protein consumption and bone fractures in women. Am J Epidemiol; 143 (5): 472–9.

    Article  PubMed  CAS  Google Scholar 

  105. Meyer HE, Pedersen JI et al. (1997) Dietary factors and the incidence of hip fractures in middle-aged Norwegians. A prospective study. Am J Epidemiol; 145 (2): 117–23.

    Article  PubMed  CAS  Google Scholar 

  106. Bonjour JP, Schurch MA et al. (1997) Proteins and bone health. Pathol Biol (Paris); 45 (1): 57–9.

    CAS  Google Scholar 

  107. Toba Y, Takada Y et al. (2000) Milk basic protein: a novel protective function of milk against osteoporosis. Bone; 27 (3): 403–8.

    Article  PubMed  CAS  Google Scholar 

  108. Aoe S, Toba Yet al. (2001) Controlled trial of the effects of milk basic protein (MBP) supplementation on bone metabolism in healthy adult women. Biosci Biotechnol Biochem; 65 (4): 913–8.

    Article  PubMed  CAS  Google Scholar 

  109. Lloyd T, Johnson-Rollings N et al. (2000) Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. J Am Coll Nutr; 19 (2): 256–61.

    PubMed  CAS  Google Scholar 

  110. Hansen SA, Folsom AR et al. (2000) Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women’s Health Study. Public Health Nutr; 3 (3): 253–61.

    Article  PubMed  CAS  Google Scholar 

  111. Baron JA, La Vecchia C et al. (1990) The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol; 162 (2): 502–14.

    PubMed  CAS  Google Scholar 

  112. Black DM, Cooper C. (2000) Epidemiology of fractures and assessment of fracture risk. Clin Lab Med; 20 (3): 439–53.

    PubMed  CAS  Google Scholar 

  113. Skis ES, Miller PD et al. (2001) Identification and fracture outcomes of undiagnosed low bone density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA; 286 (22): 2815–2822.

    Article  Google Scholar 

  114. Baron JA, Farahmand BY et al. (2001) Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Int Med; 161 (7): 983–988.

    Article  CAS  Google Scholar 

  115. Barton DL, Loprinzi CL et al. (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol; 16 (2): 495–500.

    CAS  Google Scholar 

  116. Welch GN. (1998) Homocysteine and atherothrombosis. NEJM; 338: 1009–15.

    Article  Google Scholar 

  117. Selhub J. (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA; 270: 2693–8.

    Article  PubMed  CAS  Google Scholar 

  118. Seibel MM (1999) The role of nutrition and nutritional supplements in women’s health. Fertil Steril; 72: 579–91.

    Article  PubMed  CAS  Google Scholar 

  119. Rude RK. (2000) Dietary magnesium intake and osteoporosis. Alt Therapies in Women’s Health; 2 (10): 73–77.

    Google Scholar 

  120. Rico H, Roca-Botran C, et al. (2000) The effect of supplemental copper on osteopenia induced by ovariectomy in rats. Menopause; 7 (6): 413–6.

    Article  PubMed  CAS  Google Scholar 

  121. Cumming RG. (1990) Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int; 47 (4): 194–201.

    Article  PubMed  CAS  Google Scholar 

  122. Cumming RG, Nevitt MC. (1997) Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res; 12 (9): 1321–9.

    Article  PubMed  CAS  Google Scholar 

  123. Storm D, Eslin R et al. (1998) Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab; 83 (11): 3817–25.

    Article  PubMed  CAS  Google Scholar 

  124. Dawson-Hughes B, Harris SS et al. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. NEJM; 337: 670–6.

    Article  PubMed  CAS  Google Scholar 

  125. Dawson-Hughes B, Harris SS et al. (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr; 72 (3): 745–50.

    PubMed  CAS  Google Scholar 

  126. Reid IR, Ames RW. (1995) Long term effects of calcium supplementation on bone loss and fracture in postmenopausal women: a randomized controlled trial. Am J Med; 98 (4): 331–5.

    Article  PubMed  CAS  Google Scholar 

  127. The role of calcium in peri-and postmenopausal women: consensus opinion of The North American Menopause Society. (2001) Menopause; 8 (2): 84–95.

    Google Scholar 

  128. Heaney RP, Dowell SD et al. (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr; 20 (3): 239–46.

    PubMed  CAS  Google Scholar 

  129. Friedenreich CM. (2001) Influence of physical activity in different age and life periods on the risk of breast cancer. Epidemiol; 12 (6): 604–12.

    Article  CAS  Google Scholar 

  130. Bravo G, Gauthier Pet al. (1996) Impact of a 12-month exercise program on the physical and psychological health of osteopenic women. JAGS; 44: 756–62.

    CAS  Google Scholar 

  131. Ivarsson T, Spetz AC et al. (1998) Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas; 29 (2): 139–46.

    Article  PubMed  CAS  Google Scholar 

  132. Hammar M, Berg Get al. (1990) Does physical exercise influence the frequency of postmenopausal hot flashes? Acta Obstet Gynecol Scand; 69 (5): 409–12.

    Article  PubMed  CAS  Google Scholar 

  133. Hammar ML, Hammar-Henriksson MB et al. (2000) Few oligo-amenorrheic athletes have vasomotor symptoms. Maturitas; 34: 219–25.

    Article  PubMed  CAS  Google Scholar 

  134. Wolff I, van Croonenborg JJ et al. (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trial in pre-and postmenopausal women. Osteoporosis Int; 9 (1): 1–12.

    Article  CAS  Google Scholar 

  135. Nguyen TV. (2000) Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res; 15 (2): 322–31.

    Article  PubMed  CAS  Google Scholar 

  136. Coupland CA, Cliffe SJ et al. (1999) Habitual physical activity and bone mineral density in postmenopausal women in England. Int J Epidemiol; 28 (2): 241–6.

    Article  PubMed  CAS  Google Scholar 

  137. Sorock GS, Bush TL et al. (1988) Physical activity and fracture risk in a free-living elderly cohort. J Gerontol; 43(5): M 134–9.

    Google Scholar 

  138. Kerr D, Ackland T et al. (2001) Resistance training over 2 years increases bone mass in calcium-replete postmenopausal women. J Bone Miner Res; 16 (1): 175–81.

    Article  PubMed  CAS  Google Scholar 

  139. Nelson ME, Fiatarone MA et al. (1994) Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized, controlled trial. JAMA; 272: 1909–14.

    Google Scholar 

  140. NIH Consensus Statement. March 27–29, 2000. Osteoporosis prevention, diagnosis and therapy; 17 (1): 1–45.

    Google Scholar 

  141. Gannon L, Hansel Set al. (1987) Correlates of menopausal hot flashes. J Behav Med; 10 (3): 277–85.

    Article  PubMed  CAS  Google Scholar 

  142. Freedman RR, Woodward S. (1992) Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol; 167: 436–9.

    PubMed  CAS  Google Scholar 

  143. Irvin JH, Domar AD et al. (1996) The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynecol; 17 (4): 202–7.

    Article  CAS  Google Scholar 

  144. Wood C. (1993) Mood change and perceptions of vitality: a comparison of the effects of relaxation, visualization, and yoga. J R Soc Med; 86 (5): 254–8.

    PubMed  CAS  Google Scholar 

  145. Wu L, Zhou X. (1998) 300 cases of menopausal syndrome treated by acupuncture. J Tradit Chin Med; 18(4): 259–62.

    Google Scholar 

  146. Kraft K, Coulon S. (1999) Effect of a standardized acupuncture treatment on complaints, blood pressure and serum lipids of hypertensive, postmenopausal women. A randomized, controlled clinical study. Forsch Komplement-armed; 6 (2): 74–9.

    Article  CAS  Google Scholar 

  147. Hammar M, Frisk Jet al. (1999) Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol; 161 (3): 853–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. F. Milan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Montgomery
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Geriatrics, University of Miami School of Medicine, Miami VA, Medical Center (11A), 1201 NW 16th St., 33125, Miami, FL, USA

    E. Paul Cherniack MD

  2. School of Medicine and Dentistry of New Jersey at Newark University Hospital, University of New Jersey-Newark, 150 Bergen Street, 07103, Newark, NJ, USA

    Neil Cherniack PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Milan, F., Montgomery, K. (2003). The Use of Complementary and Alternative Therapies in Older Women. In: Cherniack, E.P., Cherniack, N. (eds) Alternative Medicine for the Elderly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05185-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05185-6_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07913-9

  • Online ISBN: 978-3-662-05185-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation